R. J. Grimer

Active 1991–2021

Also published as
R.J. Grimer
107
Papers
18,307
Citations
85
h-index
107
i10-index

Citations

Citations per year for R. J. Grimer1993: 1 citations1994: 3 citations1995: 3 citations1996: 5 citations1997: 8 citations1998: 12 citations1999: 17 citations2000: 24 citations2001: 27 citations2002: 40 citations2003: 41 citations2004: 27 citations2005: 54 citations2006: 61 citations2007: 71 citations2008: 59 citations2009: 91 citations2010: 117 citations2011: 80 citations2012: 91 citations2013: 94 citations2014: 120 citations2015: 112 citations2016: 140 citations2017: 125 citations2018: 102 citations2019: 518 citations2020: 561 citations2021: 484 citations2022: 327 citations2023: 182 citations2024: 381 citations2025: 113 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 980 citing papers, 22.5% of this breakdownChina: 448 citing papers, 10.3% of this breakdownUnited Kingdom: 401 citing papers, 9.2% of this breakdownItaly: 317 citing papers, 7.3% of this breakdownGermany: 266 citing papers, 6.1% of this breakdownFrance: 212 citing papers, 4.9% of this breakdownNetherlands: 196 citing papers, 4.5% of this breakdownJapan: 178 citing papers, 4.1% of this breakdownCanada: 128 citing papers, 2.9% of this breakdownSpain: 98 citing papers, 2.2% of this breakdownSwitzerland: 91 citing papers, 2.1% of this breakdownAustria: 81 citing papers, 1.8% of this breakdown
0%22.5%Other 22.1%

Fields

  • Medicine83.8%
  • Biochemistry, Genetics and Molecular Biology10.1%
  • Engineering2.5%
  • Immunology and Microbiology1.9%
  • Materials Science0.3%
  • Computer Science0.2%
  • Other1.2%

Topics

  • Sarcoma Diagnosis and Treatment21.2%
  • Bone Tumor Diagnosis and Treatments10.2%
  • Management of metastatic bone disease4.2%
  • Orthopedic Infections and Treatments3.3%
  • Orthopaedic implants and arthroplasty3.3%
  • Oral and Maxillofacial Pathology2.4%
  • Other55.4%

Coauthors

All papers

Open in search
  1. Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Thomas Kühne, Leo Kager, Thekla von Kalle, Edita Kabíčková, Susanna Lang, Ching C. Lau, Patrick J. Leavey, Stephen L. Lessnick, Leo Mascarenhas, Regine Mayer‐Steinacker, Paul A. Meyers, Raj Nagarajan, R. Lor Randall, Peter Reichardt, Marleen Renard, Catherine Rechnitzer, Cindy L. Schwartz, Sandra J. Strauss, Lisa A. Teot, Beate Timmermann, Matthew R. Sydes, Neyssa Marina - European Journal of Cancer 2019 cited by 726

  2. UK guidelines for the management of soft tissue sarcomas

    Authors: , , , , , - Clinical Sarcoma Research 2016 cited by 489

  3. Ewing Sarcoma: Current Management and Future Approaches Through Collaboration

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2015 cited by 733

  4. Denosumab in patients with giant-cell tumour of bone: a multicentre, open-label, phase 2 study

    Authors: , , , , , , , , , , , , , , - The Lancet Oncology 2019 cited by 253

  5. Guidelines for the Management of Soft Tissue Sarcomas

    Authors: , , , - Sarcoma 2010 cited by 430

  6. EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Paul A. Meyers, Carol D. Morris, Hubert Mottl, Helen Nadel, Rajaram Nagarajan, R. Lor Randall, Paula J. Schomberg, R. Schwarz, Lisa A. Teot, Matthew R. Sydes, Mark L. Bernstein, James D. Pickering, Nicola Joffe, Matthias Kevric, Benjamin Sorg, Doojduen Villaluna, Caroline Wang, Martha Perisoglou, Leonardo Trani, Jenny Potratz, D. Carrle, Miriam Wilhelm, Katja Zils, C. Teske - Annals of Oncology 2014 cited by 333

  7. UK guidelines for the management of bone sarcomas

    Authors: , , , , , , , , , - Clinical Sarcoma Research 2016 cited by 248

  8. Denosumab treatment of inoperable or locally advanced giant cell tumor of bone – Multicenter analysis outside clinical trial

    Authors: , , , , , , , , , , , , , , , , - European Journal of Surgical Oncology 2018 cited by 112

  9. Improvement in Histologic Response But Not Survival in Osteosarcoma Patients Treated With Intensified Chemotherapy: A Randomized Phase III Trial of the European Osteosarcoma Intergroup

    Authors: , , , , , , , , , , , , , - JNCI Journal of the National Cancer Institute 2007 cited by 347

  10. Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study

    Authors: , , , , , , , , , , , , , , , - The Lancet Oncology 2013 cited by 583

  11. Fusion of SYT to two genes, SSX1 and SSX2, encoding proteins with homology to the Kruppel‐associated box in human synovial sarcoma.

    Authors: , , , , , , , , - The EMBO Journal 1995 cited by 477

  12. Early symptoms of bone and soft tissue sarcomas: could they be diagnosed earlier?

    Authors: , - Annals of The Royal College of Surgeons of England 2012 cited by 92

  13. The incidence of deep prosthetic infections in a specialist orthopaedic hospital

    Authors: , , , , - Journal of Bone and Joint Surgery - British Volume 2006 cited by 518

  14. Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trials

    Authors: , , , , , , , , , , , , , , - Annals of Oncology 2011 cited by 205

  15. The role of surgical margins in chondrosarcoma

    Authors: , , , , , - European Journal of Surgical Oncology 2018 cited by 119

  16. Surgical options for children with osteosarcoma

    Authors: - The Lancet Oncology 2005 cited by 240

  17. Dedifferentiated chondrosarcoma: Prognostic factors and outcome from a European group

    Authors: , , , , , , , , - European Journal of Cancer 2007 cited by 230

  18. Incidence, Predictive Factors, and Prognosis of Chondrosarcoma in Patients with Ollier Disease and Maffucci Syndrome: An International Multicenter Study of 161 Patients

    Authors: , , , , , , , , , , , , , , , , , - The Oncologist 2011 cited by 215

  19. Very long-term outcomes after endoprosthetic replacement for malignant tumours of bone

    Authors: , , , , , , - The Bone & Joint Journal 2016 cited by 203

  20. Prognostic factors and outcomes for osteosarcoma: An international collaboration

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , John P. A. Ioannidis - European Journal of Cancer 2009 cited by 195

  21. Inadvertent excision of malignant soft tissue tumours

    Authors: , , - EFORT Open Reviews 2019 cited by 44

  22. Endoprosthetic replacement of the distal femur for bone tumours

    Authors: , , , , - Journal of Bone and Joint Surgery - British Volume 2007 cited by 274

  23. The effect of an unplanned excision of a soft-tissue sarcoma on prognosis

    Authors: , , , , , - Journal of Bone and Joint Surgery - British Volume 2008 cited by 190

  24. Surgical Downstaging in an Open-Label Phase II Trial of Denosumab in Patients with Giant Cell Tumor of Bone

    Authors: , , , , , , , , , , , - Annals of Surgical Oncology 2015 cited by 186